Virpax Pharmaceuticals's total assets for Q4 2024 were $1.56M, an increase of 411.44% from the previous quarter. VRPX total liabilities were $2.47M for the fiscal quarter, a 4.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.